1984
DOI: 10.1038/icb.1984.21
|View full text |Cite
|
Sign up to set email alerts
|

Organotin Implications in Anticarcinogenesis. Effects of Several Organotins on Tumour Growth Rate in Mice

Abstract: Summary Several cohorts of cancerous mice were continuously dosed with 2,2′‐bipyridyl dibutyltin dichloride, 1,10‐phenanthroline dibutyltin and histidine dibutyltin; presented at 1 ppm and 10 ppm in drinking water. Tumour growth rates were significantly reduced. Tributyltin fluoride (TBTF) applied dermally, using dimethyl sulfoxide (DMSO) as the carrier, over the tumour site was ineffective. Variation in thymus and spleen weight between controls and tin‐exposed mice indicates a lymphatic involvement. Analysis … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0
1

Year Published

1987
1987
2018
2018

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(5 citation statements)
references
References 3 publications
1
3
0
1
Order By: Relevance
“…Melasoprol is the only drug that can cure Rhodesian and Gambian sleeping sicknesses both during early and late stages and low doses of arsenic trioxide and melasoprol are reported to reduce the viability and induce death in myeloma cell lines and in acute promyelocytic leukemia (Soignet et al 1998;Rousselot et al 1999). This dual therapeutic ability of organometallics is consistent with our present results and those of others (Cardarelli et al 1984;Crowe et al 1984;Nok et al 1992;Susperregui et al 1999;Shuaibu et al 2000;Bonire and Fricker. 2001;Ronconi et al 2002).…”
Section: Discussionsupporting
confidence: 95%
“…Melasoprol is the only drug that can cure Rhodesian and Gambian sleeping sicknesses both during early and late stages and low doses of arsenic trioxide and melasoprol are reported to reduce the viability and induce death in myeloma cell lines and in acute promyelocytic leukemia (Soignet et al 1998;Rousselot et al 1999). This dual therapeutic ability of organometallics is consistent with our present results and those of others (Cardarelli et al 1984;Crowe et al 1984;Nok et al 1992;Susperregui et al 1999;Shuaibu et al 2000;Bonire and Fricker. 2001;Ronconi et al 2002).…”
Section: Discussionsupporting
confidence: 95%
“…14,15,19 Compounds with a Sn-O linkage have been shown to have better activity than compounds that have tin(IV) connected to sulfur. 20,21 For tri-n-alkyltin(IV) acetates, the methyl organotin(IV) compounds are the most active in insects and mammals while the propyl and butyl compounds are the most active in fungi and certain bacteria. Activity decreases as the number of alkyl groups decreases as follows R 4 Sn >R 3 Sn > R 2 Sn > RSn > Sn all for tin(IV) compounds with the anionic X group exerting little influence on activity.…”
Section: Biological Activitiesmentioning
confidence: 99%
“…Organotins (R y SnX 4-y ) are compounds that possess direct tin-carbon covalent bond(s) that are responsible for their various toxicological/biological properties. Of the four classes of these compounds, diorganotins (IV) [R 2 SnX 2 ] (R=hydrocarbon group; X=halogen or other anionic organic compounds) are the largest group of organotins studied for antitumor activity, and 50% of these compounds show reproducible activity against various kinds of tumor (Cardarelli et al 1984;Crowe et al 1984; Bara et al 1991;Ronconi et al 2002). They are also reported to have trypanocidal activity (Nok et al 1992;Susperregui et al 1999;Shuaibu et al 2000Shuaibu et al , 2003.…”
Section: Introductionmentioning
confidence: 96%